(238 days)
These instruments (sphincterotomes and guidewires) have been designed to be used with an Olympus endoscope for papillotomy using high-frequency current. The preloaded guidewire is used for guiding and exchanging endoscopic accessories for biliary duct, including but not limited to the common bile, cystic, pancreatic and right and left hepatic ducts.
The subject sphincterotome consists of sphincterotome and preloaded guidewire. It is used in combination with endoscope and electrosurgical unit for papillotomy. The subject sphincterotome is composed of handle section and insertion tube. The preloaded guidewire is used for insertion and exchange of endotherapy accessories including the subject sphincterotome.
The provided text is a 510(k) summary for a medical device (Single Use Preloaded Sphincterotome V) seeking substantial equivalence to predicate devices. It describes the device, its intended use, technological characteristics, and non-clinical testing performed.
However, the document does not contain information about acceptance criteria or a study proving that the device meets specific performance metrics in a way that aligns with the requested format (e.g., sensitivity, specificity, accuracy, or similar quantitative performance outcomes compared against expert-established ground truth).
The "Summary of Non-clinical Testing" section states that:
- "Performance testing was conducted to demonstrate the initial performance of the subject device and confirmed that the subject device works as intended."
- "Basic safety and performance testing was performed in accordance with !EC 60601-1, IEC 60601-1-1, IEC 60601-1-2, IEC 60601-2-2 and IEC 60601-2-18. In addition, verification was conducted to evaluate the mechanical and functional performance."
- "Risk analysis was carried out in accordance with established in-house acceptance criteria based on ISO 14971:2007. The design verifications tests and their acceptance criteria were identified and performed as a result of this risk analysis assessment."
This language indicates that internal testing was done against established acceptance criteria, but it does not provide the specifics of those criteria or the results in a quantifiable, comparative manner (e.g., a table of acceptance criteria vs. device performance with specific metrics).
The document is primarily focused on demonstrating substantial equivalence based on technological characteristics and compliance with recognized safety and performance standards for an electrosurgical accessory, rather than reporting on a clinical or AI-driven performance study with detailed metrics against a ground truth.
Therefore, it is not possible to fill out the requested table and provide the specific details about a study proving the device meets acceptance criteria as typically found in submissions for AI/ML-driven devices. The provided text describes compliance with general safety and performance standards and risk analysis-driven design verification, not a study evaluating diagnostic performance against a ground truth.
{0}------------------------------------------------
K122505
page 1 of 3
510(k) SUMMARY
Single Use Preloaded Sphincterotome V
APR 1 1 2013
August 15, 2012
:
1 General Information
| Applicant: | OLYMPUS MEDICAL SYSTEMS CORP.2951 Ishikawa-cho, Hachioji-shi, Tokyo, Japan 192-8507Establishment Registration No: 8010047 | |
|---|---|---|
| 제 | Official Correspondent: | Sheri L. MusqnungRegulatory Affairs & Quality AssuranceOlympus America Inc.3500 Corporate ParkwayPO Box 610Center Valley, PA 18034-0610, USAPhone: 484-896-3147FAX: 484-896-7128Email: sheri.musqnuna@olympus.com |
| 1 | Manufacturer: | Aomori Olympus Co., Ltd.248-1 Okkonoki 2-chome Kuroishi-shi,Aomori, Japan 036-0367 |
Establishment Registration No.: 9614641
Device Identification 2
| Device Trade Name: | Single Use Preloaded Sphincterotome V |
|---|---|
| Common Name: | Sphincterotome |
| Regulation Number: | 21 CFR 876.4300 |
| Regulation Name: | Endoscopic electrosurgical unit and accessories |
| Regulatory Class: | II |
| Classification Panel: | Gastroenterology/Urology |
| Product Code: | KNS |
Predicate Device Information 3
| Manufacturer | Device Name | 510(k) Number |
|---|---|---|
| Olympus MedicalCorp. | KD 6G1-9Q Wire GuidedPapillotomy Knife | K950166 |
| Terumo Corporation | Single Use Guidewire | K091417 |
{1}------------------------------------------------
Device Description 4
The subject sphincterotome consists of sphincterotome and preloaded guidewire. It is used in combination with endoscope and electrosurgical unit for papillotomy. The subject sphincterotome is composed of handle section and insertion tube. The preloaded guidewire is used for insertion and exchange of endotherapy accessories including the subject sphincterotome.
5 Indications for Use
These instruments (sphincterotomes and quidewires) have been designed to be used with an Olympus endoscope for papillotomy using high-frequency current. The preloaded guidewire is used for guiding and exchanging endoscopic accessories for billary duct, including but not limited to the common bile, cystic, pancreatic and right and left hepatic ducts.
6 Comparison of Technological Characteristics
Compared to the predicate papillotomy knife, the subject sphincterotome has precurved distal end, coating on the cutting wire, three-lumen tube, and preloaded guidewire.
7 Substantial Equivalence Discussion
The indications for use of the subject sphincterotome is the combination of that of the predicate papillotomy knife and guidewire. The subject sphincterotome and predicate papillotomy knife are both used for endoscopic papillotomy with electrosurgical unit, and the guidewire is for guiding and exchanging endoscopic accessories including the subject sphincterotome.
Both of the subject sphincterotome and predicate papillotomy knife consist of handle section and insertion tube.
The major differences are as follows:
- . The subject sphincterotome is guidewire-preloaded.
- The distal end of subject device is precurved. .
- . Coating is applied on the cutting wire.
- C-hook is provided in the handle section of the subject sphincterotome.
The preloaded guidewire is identical to the predicate except stenlization process, however, both the subject and predicate guidewire is sterilized by ETO.
These modifications do not raise any problems on the safety or effectiveness of the subject device.
8 Summary of Non-clinical Testing
The following biocompatibility tests were performed:
- Cytotoxicity Test A.
- в. Maximization Sensitization Test
{2}------------------------------------------------
C. Intracutaneous Irritation Test
- D. Systemic Toxicity Test
Performance testing was conducted to demonstrate the initial performance of the subject device and confirmed that the subject device works as intended.
Basic safety and performance testing was performed in accordance with !EC 60601-1, IEC 60601-1-1, IEC 60601-1-2, IEC 60601-2-2 and IEC 60601-2-18. In addition, verification was conducted to evaluate the mechanical and functional performance.
Risk analysis was carried out in accordance with established in-house acceptance criteria based on ISO 14971:2007. The design verifications tests and their acceptance criteria were identified and performed as a result of this risk analysis assessment.
The following standards have been applied to the Single Use Preloaded Sphincterotome V:
- · IEC 60601-1: 1988, Amendment 1: 1991, Amendment 2: 1995
- · IEC 60601-1-1: 2000
- · IEC 60601-1-2: 2001, Amendment 1: 2004
- · IEC 60601-2-2: 2006
- · IEC 60601-2-18: 1996, Amendment 1: 2000
- · ISO 10993-1: 2009
- · ISO 10993-5: 2009
- · ISO 10993-10: 2010
- · ISO 10993-11: 2006
- · ISO 11135-1: 2003
- · ISO 14971: 2007
- · ASTM F1980-07: 2007
. 9 Conclusion
When compared to the predicate device, the Single Use Preloaded Sohincterotome V does not incorporate any significant changes in intended use, method of operation, material, or design that could affect the safety or effectiveness of the device.
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three curved lines.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
April 11, 2013
OLYMPUS MEDICAL SYSTEMS CORP. % Ms. Sheri Musgnung Associate Manager, Regulatory Affairs Olympus America Inc. 3500 Corporate Parkway, P.O. Box 610 CENTER VALLEY PA 18034-0610
Re: K122505
Trade/Device Name: Single Use Preloaded Sphincterotome V Regulation Number: 21 CFR§ 876.4300 Regulation Name: Endoscopic electrosurgical unit and accessories Regulatory Class: II Product Code: KNS Dated: February 21, 2013 Received: February 25, 2013
Dear Ms. Musgnung:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
{4}------------------------------------------------
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Herbert P.Lerner -S
for
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
Indications for Use
510(k) Number (if known): K122505
Device Name: Single Use Preloaded Sphincterotome V Indications For Use:
These instruments (sphincterotomes and guidewires) have been designed to be used with an Olympus endoscope for papillotomy using high-frequency current. The preloaded guidewire is used for guiding and exchanging endoscopic accessories for biliary duct, including but not limited to the common bile, cystic, pancreatic and right and left hepatic ducts.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of __1
Herbert P Lerner -S
(Division Sign-Off) Division of Reproductive, Gastro-Renal, and Urological Devices K122505 510(k) Number _
9
§ 876.4300 Endoscopic electrosurgical unit and accessories.
(a)
Identification. An endoscopic electrosurgical unit and accessories is a device used to perform electrosurgical procedures through an endoscope. This generic type of device includes the electrosurgical generator, patient plate, electric biopsy forceps, electrode, flexible snare, electrosurgical alarm system, electrosurgical power supply unit, electrical clamp, self-opening rigid snare, flexible suction coagulator electrode, patient return wristlet, contact jelly, adaptor to the cord for transurethral surgical instruments, the electric cord for transurethral surgical instruments, and the transurethral desiccator.(b)
Classification. Class II (performance standards).